Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Hayden

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Behavioral Medicine (Washington, D.C.)|January 11, 1992
Development of common cold symptoms following experimental rhinovirus infection is related to prior stressful life eventsA A Stone, D H Bovbjerg, J M Neale, et al.
Antiviral Research|June 16, 2000
Current research on influenza and other respiratory viruses: II international symposiumF M Munoz, G J Galasso, J M Gwaltney, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1987
Oral ribavirin treatment of influenza A and BD S Stein, C M Creticos, G G Jackson, et al.
The New England Journal of Medicine|October 28, 1999
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenzaF G Hayden, R L Atmar, M Schilling, et al.
The Annals of Otology, Rhinology, and Laryngology|July 1, 1993
Therapeutic effects of an anticholinergic-sympathomimetic combination in induced rhinovirus coldsW J Doyle, D K Riker, T P McBride, et al.
The Journal of Allergy and Clinical Immunology|September 11, 1992
Physiologic abnormalities in the paranasal sinuses during experimental rhinovirus coldsB W Turner, W S Cail, J O Hendley, et al.
Antiviral Therapy|November 15, 2000
Oral oseltamivir in human experimental influenza B infectionF G Hayden, L Jennings, R Robson, et al.
JAMA|May 26, 1999
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trialR B Turner, M T Wecker, G Pohl, et al.
Infection Control and Hospital Epidemiology|October 1, 1996
Prevention of nosocomial influenzaK A Adal, R H Flowers, A M Anglim, et al.
The Journal of Infectious Diseases|June 1, 1993
Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and controlJ A Jernigan, B S Lowry, F G Hayden, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Behavioral Medicine (Washington, D.C.)|January 11, 1992
Development of common cold symptoms following experimental rhinovirus infection is related to prior stressful life eventsA A Stone, D H Bovbjerg, J M Neale, et al.
Antiviral Research|June 16, 2000
Current research on influenza and other respiratory viruses: II international symposiumF M Munoz, G J Galasso, J M Gwaltney, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1987
Oral ribavirin treatment of influenza A and BD S Stein, C M Creticos, G G Jackson, et al.
The New England Journal of Medicine|October 28, 1999
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenzaF G Hayden, R L Atmar, M Schilling, et al.
The Annals of Otology, Rhinology, and Laryngology|July 1, 1993
Therapeutic effects of an anticholinergic-sympathomimetic combination in induced rhinovirus coldsW J Doyle, D K Riker, T P McBride, et al.
The Journal of Allergy and Clinical Immunology|September 11, 1992
Physiologic abnormalities in the paranasal sinuses during experimental rhinovirus coldsB W Turner, W S Cail, J O Hendley, et al.
Antiviral Therapy|November 15, 2000
Oral oseltamivir in human experimental influenza B infectionF G Hayden, L Jennings, R Robson, et al.
JAMA|May 26, 1999
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trialR B Turner, M T Wecker, G Pohl, et al.
Infection Control and Hospital Epidemiology|October 1, 1996
Prevention of nosocomial influenzaK A Adal, R H Flowers, A M Anglim, et al.
The Journal of Infectious Diseases|June 1, 1993
Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and controlJ A Jernigan, B S Lowry, F G Hayden, et al.
Pageof 18